|
YY1AP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.49809994701656E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.68129998601563E-09 |
| Normal-vs-Stage2 |
2.36600000036447E-07 |
| Normal-vs-Stage3 |
2.60840000043672E-07 |
| Normal-vs-Stage4 |
1.559200E-04 |
| Stage1-vs-Stage2 |
4.373200E-01 |
| Stage1-vs-Stage3 |
7.546600E-01 |
| Stage1-vs-Stage4 |
3.745600E-01 |
| Stage2-vs-Stage3 |
3.875600E-01 |
| Stage2-vs-Stage4 |
2.078600E-01 |
| Stage3-vs-Stage4 |
5.832200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2452000036921E-08 |
| Normal-vs-AfricanAmerican |
4.580300E-02 |
| Normal-vs-Asian |
3.34999999995755E-06 |
| Caucasian-vs-AfricanAmerican |
6.384000E-02 |
| Caucasian-vs-Asian |
5.237200E-01 |
| AfricanAmerican-vs-Asian |
1.210220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12259999995867E-06 |
| Normal-vs-Female |
9.17860010218874E-10 |
| Male-vs-Female |
3.014400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.24919996148077E-09 |
| Normal-vs-Age(41-60Yrs) |
7.30220000022541E-08 |
| Normal-vs-Age(61-80Yrs) |
1.50460000003516E-06 |
| Normal-vs-Age(81-100Yrs) |
3.108000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.893000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.045400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.200800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.584200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.987200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.389800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.561900E-03 |
| Classical-VS-Follicular |
4.167700E-04 |
| Classical-VS-Other |
9.736400E-02 |
| Classical-VS-Normal |
1.4207999999849E-06 |
| Tall-VS-Follicular |
9.963800E-01 |
| Tall-VS-Other |
8.226000E-01 |
| Tall-VS-Normal |
2.31169999809211E-08 |
| Follicular-VS-Other |
8.525800E-01 |
| Follicular-VS-Normal |
2.07269978957925E-10 |
| Other-VS-Normal |
4.994600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.19809995047638E-09 |
| Normal-vs-N1 |
2.17590001572177E-09 |
| N0-vs-N1 |
3.349600E-01 |
|
|
